SCHEMBL7250077

SCHEMBL7250077

COC(=O)c1cc(NC(=O)c2ccc(C)c([N+](=O)[O-])c2)c(SC)s1.CSc1sc(C(=N)N)cc1NC(=O)C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 3/20 0.42
PDE5A O76074 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGD P15428 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 4/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.38
HSP90AA1 P07900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6926572 0.85 MEN1 (0.55) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL6925248 0.78 C1S (0.47) SMN1; SMN2MEN1KMT2ARAB9AHTT
SCHEMBL6926488 0.78 ALDH1A1 (0.49) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL7736081 0.74 MEN1 (0.59) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL6923971 0.67 ALDH1A1 (0.54) MEN1KMT2ANPC1RAB9ACYP1A2
SCHEMBL7246338 0.67 KMT2A (0.53) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL6923589 0.66 PLAU (0.47) MEN1KMT2ANPC1RAB9ACYP1A2
SCHEMBL6920494 0.66 KMT2A (0.53) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL6920041 0.66 MEN1 (0.56) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL6926094 0.66 HPGD (0.53) MEN1KMT2ARAB9AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562840-B1 Non-peptidic inhibitors of proteolytic enzymes such as urokinase 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-05-13 US disclosed
US-6403633-B2 USEFUL ANTIANGIOGENIC, ANTIARTHRITIC, ANTIINFLAMMATORY, ANTIRESTENOTIC, ANTIINVASIVE, ANTIMETASTIC, ANTIOSTEOPOROTIC, ANTIRETINOPATHIC, CONTRACEPTIVE AND TUMORISTATIC TREATMENT AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-06-11 US disclosed
EP-1150979-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-11-07 EP disclosed
WO-2000047578-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed